Theravance Biopharma, Inc. (TBPH) Estimates

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Revenue Estimates

Quarterly Annual

Metric	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27	Q2 27	Q3 27	Q4 27	Q1 28	Q2 28	Q3 28	Q4 28	Q1 29	Q2 29	Q3 29	Q4 29	Q1 30	Q2 30	Q3 30	Q4 30
Reported (Actual)	14.26 M	16.87 M	18.75 M	15.39 M	26.20 M	19.99 M	45.89 M	17.70 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Estimate	16.48 M	16.98 M	19.92 M	15.30 M	28.35 M	21.78 M	58.35 M	19.48 M	25.30 M	23.31 M	47.85 M	25.36 M	33.99 M	26.31 M	59.45 M	20.31 M	25.42 M	18.26 M	39.10 M	20.11 M	26.85 M	22.58 M	44.84 M	24.62 M	34.28 M	28.71 M	71.45 M
Low Estimate	14.99 M	15.81 M	16.31 M	14.11 M	24.77 M	19.72 M	49.32 M	16.86 M	20.75 M	21.50 M	45.00 M	22.31 M	27.97 M	24.51 M	52.46 M	16.96 M	22.91 M	16.73 M	35.51 M	17.96 M	23.09 M	19.53 M	40.13 M	20.47 M	28.95 M	26.04 M	58.95 M
Consensus Estimate	15.73 M	16.39 M	18.12 M	14.70 M	26.56 M	20.75 M	53.83 M	18.17 M	23.03 M	22.41 M	46.42 M	23.83 M	30.98 M	25.41 M	55.96 M	18.64 M	24.16 M	17.49 M	37.31 M	19.03 M	24.97 M	21.06 M	42.48 M	22.54 M	31.61 M	27.38 M	65.20 M

Earnings Per Share (EPS) Estimates

Quarterly Annual

Metric	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27	Q2 27	Q3 27	Q4 27	Q1 28	Q2 28	Q3 28	Q4 28	Q1 29	Q2 29	Q3 29	Q4 29	Q1 30	Q2 30	Q3 30	Q4 30
Reported (Actual)	-0.34	-0.26	-0.31	-0.27	1.08	0.07	1.15	-0.10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Estimate	-0.19	-0.22	-0.19	-0.20	0.75	-0.11	1.12	0.03	0.07	0.22	1.79	0.29	0.44	0.18	1.71	0.04	0.35	-0.07	1.12	0.01	0.45	-0.03	1.18	0.28	0.82	0.36	1.81
Low Estimate	-0.21	-0.26	-0.23	-0.24	0.63	-0.13	0.94	0.03	0.07	0.18	1.61	0.25	0.38	0.16	1.45	0.04	0.31	-0.09	0.94	0.01	0.39	-0.03	1.10	0.24	0.74	0.34	1.65
Consensus Estimate	-0.20	-0.24	-0.21	-0.22	0.69	-0.12	1.03	0.03	0.07	0.20	1.70	0.27	0.41	0.17	1.58	0.04	0.33	-0.08	1.03	0.01	0.42	-0.03	1.14	0.26	0.78	0.35	1.73

Theravance Biopharma (TBPH)

NASDAQ: TBPH

$16.97 ▲ +0.05 (+0.30%)

Aug 14, 2026 · 4:00 PM UTC